Product Information
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0787 per ML under NDC 00378967130. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Oct 1, 2012. Its Orange Book therapeutic-equivalence code is AN.
Strength
2.5; .5 mg/3mL; mg/3mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378967130
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATE; IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202496FDA Approved
10/1/2012
TE Code
AN
On Market Since
3/1/2013
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has been published 542 times since May 18, 2016, and over the history we have for it it has declined 97.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per ML |
|---|---|
| All-time high | $3.4424 (Jul 20, 2016) |
| All-time low | $0.0520 (Nov 21, 2018) |
| 52-week high | $0.0926 |
| 52-week low | $0.0787 |
| Median price | $0.0688 |
| Average price | $0.1346 |
| Largest weekly change | -98.0% (Jul 27, 2016) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide and Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, manufactured by Mylan Pharmaceuticals Inc., is $0.0787 per ML (NDC 00378967130), effective Sep 30, 2026.
How has the price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has declined 97.7%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
Since May 18, 2016, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has ranged from a low of $0.0520 (Nov 21, 2018) to a high of $3.4424 (Jul 20, 2016), with a median of $0.0688 per ML.
Are there cheaper alternatives to IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML (NDC 00378967130) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.